The Implication of Neuronimmunoendocrine (NIE) Modulatory Network in the Pathophysiologic Process of Parkinson's Disease.

Yan Shen,Xingfang Guo,Chao Han,Fang Wan,Kai Ma,Shiyi Guo,Luxi Wang,Yun Xia,Ling Liu,Zhicheng Lin,Jinsha Huang,Nian Xiong,Tao Wang

DOI: https://doi.org/10.1007/s00018-017-2549-2

IF: 8

2017-01-01

Cellular and Molecular Life Sciences

Abstract:Parkinson's disease (PD) is a progressive neurodegenerative disorder implicitly marked by the substantia nigra dopaminergic neuron degeneration and explicitly characterized by the motor and non-motor symptom complexes. Apart from the nigrostriatal dopamine depletion, the immune and endocrine study findings are also frequently reported, which, in fact, have helped to broaden the symptom spectrum and better explain the pathogenesis and progression of PD. Nevertheless, based on the neural, immune, and endocrine findings presented above, it is still difficult to fully recapitulate the pathophysiologic process of PD. Therefore, here, in this review, we have proposed the neuroimmunoendocrine (NIE) modulatory network in PD, aiming to achieve a more comprehensive interpretation of the pathogenesis and progression of this disease. As a matter of fact, in addition to the classical motor symptoms, NIE modulatory network can also underlie the non-motor symptoms such as gastrointestinal, neuropsychiatric, circadian rhythm, and sleep disorders in PD. Moreover, the dopamine (DA)-melatonin imbalance in the retino-diencephalic/mesencephalic-pineal axis also provides an alternative explanation for the motor complications in the process of DA replacement therapy. In conclusion, the NIE network can be expected to deepen our understanding and facilitate the multi-dimensional management and therapy of PD in future clinical practice.